Saudi Arabia has reported five new deaths from the MERS respiratory virus, bringing the death toll in the world's worst-hit country to 168.
Health authorities in Saudi Arabia on Thursday announced the deaths of another three people from the MERS respiratory virus, taking the country's toll to 160.
(Medical Xpress)—Children who receive antibiotics before their first birthday might be at a slightly increased risk of developing asthma. However, new research by The University of Manchester suggests that ...
(HealthDay)—Two Florida hospital workers who helped treat a man with the second diagnosed case of MERS in the United States have developed respiratory symptoms, according to published reports.
A second case of the dangerous Middle East respiratory virus, called MERS, has been found in the United States, health authorities said Monday.
Saudi Arabia's death toll from MERS has risen by five to 126 fatalities since the mystery respiratory virus first appeared in the kingdom in 2012, the health ministry said Friday.
Lebanon has recorded its first case of the often-fatal Middle East respiratory virus, the Health Ministry said Friday.
The first US patient sickened by the dangerous Middle East respiratory virus, MERS, is doing better and no other cases have emerged, American health officials said Monday.
Saudi health authorities announced on Monday that the death toll from the MERS coronavirus has reached 115 since the respiratory disease first appeared in the kingdom in 2012.
(HealthDay)—A man hospitalized in Indiana with the first U.S. case of a deadly respiratory virus that initially surfaced in the Middle East two years ago is improving, state health officials reported Satu ...
The first case of MERS, a dangerous respiratory virus that originated in the Middle East and has a high death rate, has been confirmed in the United States, officials said Friday.
National Institutes of Health (NIH) researchers have developed an animal model of human hantavirus pulmonary syndrome (HPS) in rhesus macaques, an advance that may lead to treatments, vaccines and improved ...
Scientists at Dana-Farber Cancer Institute have identified natural human antibodies against the virus that causes Middle East Respiratory Syndrome (MERS), a step toward developing treatments for the newly ...
(HealthDay)—The U.S. Food and Drug Administration has approved Sylvant (siltuximab) to treat patients with multicentric Castleman's disease (MCD), according to a news release issued by the agency today.
(Medical Xpress)—Scots scientists have developed a novel treatment that could protect against any strain of the flu.